SERINC5, serine incorporator 5, 256987

N. diseases: 8; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0272178
Disease: Drug-induced neutropenia
Drug-induced neutropenia
0.100 GeneticVariation disease GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467 2018
Human immunodeficiency virus (HIV) II infection category B1
0.040 AlteredExpression disease BEFREE In the absence of viral antagonists, rodent and lagomorph SERINC3 and SERINC5 displayed anti-HIV activity in a similar range to human controls. 30566072 2019
Human immunodeficiency virus (HIV) II infection category B1
0.040 Biomarker disease BEFREE SERINC5 as a New Restriction Factor for Human Immunodeficiency Virus and Murine Leukemia Virus. 30265629 2018
Human immunodeficiency virus (HIV) II infection category B1
0.040 Biomarker disease BEFREE We conclude that Nef uses a similar mechanism to downregulate Ser5 and CD4, which sorts Ser5 into a point-of-no-return degradative pathway to counteract its restriction.<b>IMPORTANCE</b> Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) express an accessory protein called Nef to promote viral pathogenesis. 29514909 2018
Human immunodeficiency virus (HIV) II infection category B1
0.040 AlteredExpression disease BEFREE Importantly, only Ser5-001 shows strong anti-HIV-1 activity. 28275190 2017
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
0.020 Biomarker disease BEFREE Collectively, these results provide new insights into our ongoing understanding of the Nef-Ser5 arms race in HIV-1 infection. 29514909 2018
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
0.020 Biomarker disease BEFREE The viral restriction factor SERINC5 inhibits HIV-1 infection via unknown mechanisms. 28389578 2017
CUI: C0023418
Disease: leukemia
leukemia
0.010 Biomarker disease BEFREE SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoGag) protein, which possesses a potent Nef-like activity on HIV-1 infectivity. 31186327 2019
CUI: C0035369
Disease: Retroviridae Infections
Retroviridae Infections
0.010 Biomarker group BEFREE Because tier 1 and tier 2/3 Env trimers have open and closed conformations, respectively, and CD4 opens the closed conformation, we conclude that SERINC5 selectively dissociates Env trimers with an open conformation to restrict HIV-1 replication.<b>IMPORTANCE</b> Restriction factors provide the first line of defense against retrovirus infection by posing several blocks to the viral replication cycle. 31043528 2019
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.010 Biomarker disease BEFREE SERINC3 and SERINC5 are also counteracted by the unrelated murine leukemia virus glycosylated Gag (glycoGag) protein, which possesses a potent Nef-like activity on HIV-1 infectivity. 31186327 2019
CUI: C0006012
Disease: Borderline Personality Disorder
Borderline Personality Disorder
0.010 Biomarker disease BEFREE We present results from a first genome-wide association study of BP features, which shows a promising signal on chromosome 5 corresponding to SERINC5, a protein involved in myelination. 23979607 2014
CUI: C0474808
Disease: Follicular neoplasm
Follicular neoplasm
0.010 Biomarker disease BEFREE The ratio tpo2 or tpo3 to tpo1 was inversed in follicular tumors. 16728576 2006